Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy, David W. Bilheimer, Alan Chait, Luther T. Clark, Margo A. Denke, Richard J. Havel, William R. Hazzard, Stephen B. Hulley, Donald B. Hunninghake, Robert A. Kreisberg, Penny M. Kris‐Etherton, James M. McKenney, Michael A. Newman, Ernst J. Schaefer, Burton E. Sobel, Carolyn A. Somelofski, Milton C. Weinstein, H. Bryan Brewer, James I. Cleeman, Karen A. Donato, Nancy D. Ernst, Jeffrey M. Hoeg, Basil M. Rifkind, Jacques Rossouw, Christopher T. Sempos, Joanne M. Gallivan, Maureen N. Harris, Laurie Quint-Adler·1993·JAMA

DOI 10.1001/jama.269.23.3015

Open this paper in CoChat — free account

Abstract

THE SECOND report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II, or ATP II) presents the National Cholesterol Education Program's updated recommendations for cholesterol management. It is similar to the first in general outline, and the fundamental approach to treatment of high blood cholesterol is comparable. This report continues to identify low-density lipoproteins (LDL) as the primary target of cholesterol-lowering therapy. As in the first report, the second report emphasizes the role of the clinical approach in primary prevention of coronary heart disease (CHD). Dietary therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD. However, the second report contains new features that distinguish it from the first. These include the following: Increased emphasis on See also pp 3002 and 3009.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

OpenAlex · 10.1001/jama.269.23.3015

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 701–800 of 1,299

Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction
Ganna, A., Magnusson, P. K. E., Pedersen, N. L., de Faire, U., Reilly, M., Ärnlöv, J., Sundström, J., Hamsten, A., & Ingelsson, E. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301218 · Cited by 156
Diabetes, Glycemic Control, and New-Onset Heart Failure in Patients With Stable Coronary Artery Disease
van Melle, J. P., Bot, M., de Jonge, P., de Boer, R. A., van Veldhuisen, D. J., & Whooley, M. A. (2010) · Diabetes Care · doi:10.2337/dc10-0286 · Cited by 159
Untitled work
(2007) · doi:10.1139/h06-102 · Cited by 160
Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects
Vega-López, S., Ausman, L. M., Jalbert, S. M., Erkkilä, A. T., & Lichtenstein, A. H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.54 · Cited by 160
Impaired glucose tolerance and impaired fasting glucose — a review of diagnosis, clinical implications and management
Petersen, J. L., & McGuire, D. K. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.007 · Cited by 159
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
Blood Lipids and First-Ever Ischemic Stroke/Transient Ischemic Attack in the Bezafibrate Infarction Prevention (BIP) Registry: High Triglycerides Constitute an Independent Risk Factor
Tanne, D., Koren-Morag, N., Graff, E., & Goldbourt, U. (2001) · Circulation · doi:10.1161/hc4901.100384 · Cited by 158
Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy
Teixeira, S. R., Tappenden, K. A., Carson, L., Erdman, J. W., Jones, R., Prabhudesai, M., & Marshall, W. P. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.8.1874 · Cited by 157
Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
Brunzell, J. D., & Ayyobi, A. F. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.011 · Cited by 155
Influence of cholesterol status on blood lipid and lipoprotein enzyme responses to aerobic exercise
Grandjean, P. W., Crouse, S. F., & Rohack, J. J. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.472 · Cited by 158
Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study
Bray, G. A. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.031 · Cited by 158
Epidemiologic aspects of lipid abnormalities
Criqui, M. H., & Golomb, B. A. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00212-5 · Cited by 158
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
Glass, T., Ungsedhapand, C., Wolbers, M., Weber, R., Vernazza, P., Rickenbach, M., Furrer, H., Bernasconi, E., Cavassini, M., Hirschel, B., et al. (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00400.x · Cited by 156
Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics
Wanner, C., Krane, V., März, W., Olschewski, M., Asmus, H.-G., Krämer, W., Kühn, K.-W., Kütemeyer, H., Mann, J. F. E., Ruf, G., et al. (2004) · Kidney and Blood Pressure Research · doi:10.1159/000080241 · Cited by 157
Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort
Fleming, D. J., Tucker, K. L., Jacques, P. F., Dallal, G. E., Wilson, P. W., & Wood, R. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.6.1375 · Cited by 153
Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins
Cohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2474 · Cited by 156
Translating Weight Loss and Physical Activity Programs Into the Community to Preserve Mobility in Older, Obese Adults in Poor Cardiovascular Health
Rejeski, W. J., Brubaker, P. H., Goff, D. C., Bearon, L. B., McClelland, J. W., Perri, M. G., & Ambrosius, W. T. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.522 · Cited by 156
Effects of a Web-Based Intervention on Physical Activity and Metabolism in Older Adults: Randomized Controlled Trial
Wijsman, C. A., Westendorp, R. G., Verhagen, E. A., Catt, M., Slagboom, P. E., de Craen, A. J., Broekhuizen, K., van Mechelen, W., van Heemst, D., van der Ouderaa, F., et al. (2013) · Journal of Medical Internet Research · doi:10.2196/jmir.2843 · Cited by 156
Statins and PCSK9 inhibitors: A new lipid-lowering therapy
Gallego-Colon, E., Daum, A., & Yosefy, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173114 · Cited by 156
Adherence to Statin Therapy and LDL Cholesterol Goal Attainment by Patients With Diabetes and Dyslipidemia
Parris, E. S., Lawrence, D. B., Mohn, L. A., & Long, L. B. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.595 · Cited by 155
β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials
AbuMweis, S. S., Jew, S., & Ames, N. P. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.178 · Cited by 155
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
Van Gaal, L. F., Scheen, A. J., Rissanen, A. M., Rössner, S., Hanotin, C., & Ziegler, O. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn076 · Cited by 156
Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?
Araujo, A. B., Hall, S. A., Ganz, P., Chiu, G. R., Rosen, R. C., Kupelian, V., Travison, T. G., & McKinlay, J. B. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.058 · Cited by 153
The Epidemiology of Central Fat Distribution in Relation to Disease
Pi-Sunyer, F. X. (2004) · Nutrition Reviews · doi:10.1111/j.1753-4887.2004.tb00081.x · Cited by 153
Effect of Sarcopenia on Cardiovascular Disease Risk Factors in Obese Postmenopausal Women
Aubertin‐Leheudre, M., Lord, C., Goulet, É. D. B., Khalil, A., & Dionne, I. J. (2006) · Obesity · doi:10.1038/oby.2006.267 · Cited by 151
Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease
Henderson, G. C. (2021) · Nutrients · doi:10.3390/nu13082590 · Cited by 152
Posttraumatic stress disorder: A metabolic disorder in disguise?
Michopoulos, V., Vester, A., & Neigh, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.038 · Cited by 152
The additive blood pressure lowering effects of exercise intensity on post‐exercise hypotension
Eicher, J. D., Maresh, C. M., Tsongalis, G. J., Thompson, P. D., & Pescatello, L. S. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.005 · Cited by 151
Statins, cognition, and dementia-systematic review and methodological commentary
Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.35 · Cited by 150
Low glycaemic index diets and blood lipids: a systematic review and meta-analysis of randomised controlled trials
Goff, L. M., Cowland, D. E., Hooper, L., & Frost, G. S. (2013) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.06.002 · Cited by 151
Metabolic syndrome: Does it differ between women and men?
Rochlani, Y., Pothineni, N. V., & Mehta, J. L. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6593-6 · Cited by 152
A comparative analysis of measurement approaches for physiological dysregulation in an older population
SEPLAKI, C., GOLDMAN, N., GLEI, D., & WEINSTEIN, M. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.03.002 · Cited by 151
Self-citation
Effects of interventions in health care settings on physical activity or cardiorespiratory fitness
Simons-Morton, D. G., Calfas, K. J., Oldenburg, B., & Burton, N. W. (1998) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00078-6 · Cited by 151
Blood Pressure and Cholesterol Control in Hypertensive Hypercholesterolemic Patients: National Health and Nutrition Examination Surveys 1988–2010
Egan, B. M., Li, J., Qanungo, S., & Wolfman, T. E. (2013) · Circulation · doi:10.1161/circulationaha.112.000500 · Cited by 150
Effect of cranberry extracts on lipid profiles in subjects with type 2 diabetes
Lee, I. T., Chan, Y. C., Lin, C. W., Lee, W. J., & Sheu, W. H. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02588.x · Cited by 150
Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage: The Ibaraki Prefectural Health Study
Noda, H., Iso, H., Irie, F., Sairenchi, T., Ohtaka, E., Doi, M., Izumi, Y., & Ohta, H. (2009) · Circulation · doi:10.1161/circulationaha.108.795666 · Cited by 150
Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: Systematic review and mixed treatment comparison meta-analysis
Dunkley, A. J., Charles, K., Gray, L. J., Camosso‐Stefinovic, J., Davies, M. J., & Khunti, K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01571.x · Cited by 151
Triglycerides as vascular risk factors: new epidemiologic insights.
Kannel, W. B., & Vasan, R. S. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832c1284 · Cited by 149
Type 2 diabetes and metabolic syndrome in Filipina-American women
Araneta, M. R. G., Wingard, D. L., & Barrett-Connor, E. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.494 · Cited by 149
Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials
Kelley, G. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2003.12.012 · Cited by 148
Derivation and Validation of Diagnostic Thresholds for Central Blood Pressure Measurements Based on Long-Term Cardiovascular Risks
Cheng, H.-M., Chuang, S.-Y., Sung, S.-H., Yu, W.-C., Pearson, A., Lakatta, E. G., Pan, W.-H., & Chen, C.-H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.029 · Cited by 148
Fibrates for primary prevention of cardiovascular disease events
Jakob, T., Nordmann, A. J., Schandelmaier, S., Ferreira-González, I., & Briel, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009753.pub2 · Cited by 147
Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation
Milani, R. V., & Lavie, C. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00464-8 · Cited by 146
A Two‐Year Randomized Weight Loss Trial Comparing a Vegan Diet to a More Moderate Low‐Fat Diet
Turner‐McGrievy, G. M., Barnard, N. D., & Scialli, A. R. (2007) · Obesity · doi:10.1038/oby.2007.270 · Cited by 143
Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults
Wijndaele, K., Duvigneaud, N., Matton, L., Duquet, W., Delecluse, C., Thomis, M., Beunen, G., Lefevre, J., & Philippaerts, R. M. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602944 · Cited by 143
Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis
Kavousi, M., Desai, C. S., Ayers, C., Blumenthal, R. S., Budoff, M. J., Mahabadi, A.-A., Ikram, M. A., van der Lugt, A., Hofman, A., Erbel, R., et al. (2016) · JAMA · doi:10.1001/jama.2016.17020 · Cited by 141
Breastfeeding and maternal cardiovascular risk factors and outcomes: A systematic review
Nguyen, B., Jin, K., & Ding, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187923 · Cited by 145
Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3204 high-risk patients
Sánchez-Taínta, A., Estruch, R., Bulló, M., Corella, D., Gómez-Gracia, E., Fiol, M., Algorta, J., Covas, M.-I., Lapetra, J., Zazpe, I., et al. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328308ba61 · Cited by 144
Prevalencia, distribución y variabilidad geográfica de los principales factores de riesgo cardiovascular en España. Análisis agrupado de datos individuales de estudios epidemiológicos poblacionales: estudio ERICE
Gabriel, R., Alonso, M., Segura, A., Tormo, M. J., Artigao, L. M., Banegas, J. R., Brotons, C., Elosua, R., Fernández-Cruz, A., Muñiz, J., et al. (2008) · Revista Española de Cardiología · doi:10.1157/13126043 · Cited by 143
Protein in optimal health: heart disease and type 2 diabetes
Layman, D. K., Clifton, P., Gannon, M. C., Krauss, R. M., & Nuttall, F. Q. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1571s · Cited by 142
Continuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Crossover Trial
Phillips, C. L., Yee, B. J., Marshall, N. S., Liu, P. Y., Sullivan, D. R., & Grunstein, R. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0316oc · Cited by 145
Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease: An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific Region
Huxley, R. R., Barzi, F., Lam, T. H., Czernichow, S., Fang, X., Welborn, T., Shaw, J., Ueshima, H., Zimmet, P., Jee, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.028373 · Cited by 144
Diet Soft Drink Consumption is Associated with an Increased Risk of Vascular Events in the Northern Manhattan Study
Gardener, H., Rundek, T., Markert, M., Wright, C. B., Elkind, M. S. V., & Sacco, R. L. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1968-2 · Cited by 143
Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events
Puri, R., Nissen, S. E., Shao, M., Elshazly, M. B., Kataoka, Y., Kapadia, S. R., Tuzcu, E. M., & Nicholls, S. J. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307601 · Cited by 143
Atherosclerotic calcification is related to a higher risk of dementia and cognitive decline
Bos, D., Vernooij, M. W., de Bruijn, R. F. A. G., Koudstaal, P. J., Hofman, A., Franco, O. H., van der Lugt, A., & Ikram, M. A. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1758 · Cited by 142
Changes in Metabolic Syndrome Variables Since Childhood in Prehypertensive and Hypertensive Subjects: The Bogalusa Heart Study
Srinivasan, S. R., Myers, L., & Berenson, G. S. (2006) · Hypertension · doi:10.1161/01.hyp.0000226410.11198.f4 · Cited by 143
Plant Sterol-Fortified Orange Juice Effectively Lowers Cholesterol Levels in Mildly Hypercholesterolemic Healthy Individuals
Devaraj, S., Jialal, I., & Vega-López, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000120784.08823.99 · Cited by 140
Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome
Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Williams, G., & Norman, R. J. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.77 · Cited by 141
Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly
Cheng, H.-T., Huang, J.-W., Chiang, C.-K., Yen, C.-J., Hung, K.-Y., & Wu, K.-D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2658 · Cited by 140
Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly
Gan, L., Chitturi, S., & Farrell, G. C. (2011) · Current Gerontology and Geriatrics Research · doi:10.1155/2011/831536 · Cited by 135
Approaches to prevention of cardiovascular complications and events in diabetes mellitus
Coccheri, S. (2007) · Drugs · doi:10.2165/00003495-200767070-00005 · Cited by 139
Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart Disease
von Eynatten, M., Hamann, A., Twardella, D., Nawroth, P. P., Brenner, H., & Rothenbacher, D. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.060509 · Cited by 140
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Medina-Caliz, I., Robles-Diaz, M., Garcia-Muñoz, B., Stephens, C., Ortega-Alonso, A., Garcia-Cortes, M., González-Jimenez, A., Sanabria-Cabrera, J. A., Moreno, I., Fernandez, M. C., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.003 · Cited by 140
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease
Wenger, N. K., Lewis, S. J., Herrington, D. M., Bittner, V., Welty, F. K., & for the Treating to New Targets Study Steering Committee and Investigators (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00002 · Cited by 139
All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals
Reaven, G. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.017 · Cited by 135
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
Olivieri, O., Bassi, A., Stranieri, C., Trabetti, E., Martinelli, N., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., & Corrocher, R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300253-jlr200 · Cited by 139
Sleep deprivation is associated with lower diet quality indices and higher rate of general and central obesity among young female students in Iran
Haghighatdoost, F., Karimi, G., Esmaillzadeh, A., & Azadbakht, L. (2012) · Nutrition · doi:10.1016/j.nut.2012.04.015 · Cited by 138
Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease
Cuthbertson, D. J., Shojaee-Moradie, F., Sprung, V. S., Jones, H., Pugh, C. J. A., Richardson, P., Kemp, G. J., Barrett, M., Jackson, N. C., Thomas, E. L., et al. (2016) · Clinical Science · doi:10.1042/cs20150447 · Cited by 138
Beyond Low-Density Lipoprotein Cholesterol
Mudd, J. O., Borlaug, B. A., Johnston, P. V., Kral, B. G., Rouf, R., Blumenthal, R. S., & Kwiterovich, P. O. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.045 · Cited by 136
Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review
Abourbih, S., Filion, K. B., Joseph, L., Schiffrin, E. L., Rinfret, S., Poirier, P., Pilote, L., Genest, J., & Eisenberg, M. J. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.03.030 · Cited by 139
Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial
Hagiwara, N., Kawada-Watanabe, E., Koyanagi, R., Arashi, H., Yamaguchi, J., Nakao, K., Tobaru, T., Tanaka, H., Oka, T., Endoh, Y., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx162 · Cited by 136
A Prospective Study of Plasma Ferritin Level and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
Jehn, M. L., Guallar, E., Clark, J. M., Couper, D., Duncan, B. B., Ballantyne, C. M., Hoogeveen, R. C., Harris, Z. L., & Pankow, J. S. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk093 · Cited by 136
Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome.
Elder, S. J., Lichtenstein, A. H., Pittas, A. G., Roberts, S. B., Fuss, P. J., Greenberg, A. S., McCrory, M. A., Bouchard, T. J., Saltzman, E., & Neale, M. C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900033-jlr200 · Cited by 139
Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria
Goverde, A. J., van Koert, A. J. B., Eijkemans, M. J., Knauff, E. A. H., Westerveld, H. E., Fauser, B. C. J. M., & Broekmans, F. J. (2008) · Human Reproduction · doi:10.1093/humrep/den433 · Cited by 135
Evidence of proatherogenic inflammation in polycystic ovary syndrome
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.022 · Cited by 135
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease
Machado, M. V., Michelotti, G. A., Pereira, T. A., Xie, G., Premont, R., Cortez-Pinto, H., & Diehl, A. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.031 · Cited by 135
Excess Weight and the Risk of Incident Coronary Heart Disease Among Men and Women
Flint, A. J., Hu, F. B., Glynn, R. J., Caspard, H., Manson, J. E., Willett, W. C., & Rimm, E. B. (2010) · Obesity · doi:10.1038/oby.2009.223 · Cited by 134
Systematic Review of Guidelines on Cardiovascular Risk Assessment: Which Recommendations Should Clinicians Follow for a Cardiovascular Health Check?
Ferket, B. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.434 · Cited by 134
National lipid association annual summary of clinical lipidology 2016
Bays, H. E., Jones, P. H., Orringer, C. E., Brown, W. V., & Jacobson, T. A. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.08.002 · Cited by 128
Effects of Intensive Lifestyle Changes on Erectile Dysfunction in Men
Esposito, K., Ciotola, M., Giugliano, F., Maiorino, M. I., Autorino, R., De Sio, M., Giugliano, G., Nicoletti, G., D’Andrea, F., & Giugliano, D. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01030.x · Cited by 132
Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia and Coronary Heart Disease: Secondary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT)
Mabuchi, H., Kita, T., Matsuzaki, M., Matsuzawa, Y., Nakaya, N., Oikawa, S., Saito, Y., Sasaki, J., Shimamoto, K., Itakura, H., et al. (2002) · Circulation Journal · doi:10.1253/circj.66.1096 · Cited by 132
The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes
Jenkins, D. J. A., Srichaikul, K., Kendall, C. W. C., Sievenpiper, J. L., Abdulnour, S., Mirrahimi, A., Meneses, C., Nishi, S., He, X., Lee, S., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1927-1 · Cited by 130
Socioeconomic differences in cardiometabolic factors: social causation or health-related selection? Evidence from the Whitehall II Cohort Study, 1991–2004
Elovainio, M., Ferrie, J. E., Singh-Manoux, A., Shipley, M., Batty, G. D., Head, J., Hamer, M., Jokela, M., Virtanen, M., Brunner, E., et al. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr149 · Cited by 131
The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia
Jenkins, D. J. A., Kendall, C. W. C., Marchie, A., Faulkner, D., Vidgen, E., Lapsley, K. G., Trautwein, E. A., Parker, T. L., Josse, R. G., Leiter, L. A., et al. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00260-9 · Cited by 131
Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
MAS, R., CASTANO, G., ILLNAIT, J., FERNANDEZ, L., FERNANDEZ, J., ALEMAN, C., PONTIGAS, V, & LESCAY, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70139-6 · Cited by 130
Sleep duration and metabolic syndrome in adult populations: a meta-analysis of observational studies
Ju, S.-Y., & Choi, W.-S. (2013) · Nutrition & Diabetes · doi:10.1038/nutd.2013.8 · Cited by 130
Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease
Patel, S. M., Ratcliffe, S. J., Reilly, M. P., Weinstein, R., Bhasin, S., Blackman, M. R., Cauley, J. A., Sutton-Tyrrell, K., Robbins, J., Fried, L. P., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0740 · Cited by 132
Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration
Balestrini, S., Perozzi, C., Altamura, C., Vernieri, F., Luzzi, S., Bartolini, M., Provinciali, L., & Silvestrini, M. (2013) · Neurology · doi:10.1212/wnl.0b013e318295d71a · Cited by 126
Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study
Subherwal, S., Patel, M. R., Kober, L., Peterson, E. D., Bhatt, D. L., Gislason, G. H., Olsen, A.-M. S., Jones, W. S., Torp-Pedersen, C., & Fosbol, E. L. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487313519344 · Cited by 129
Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients.
Lins, R. L., Matthys, K. E., Verpooten, G. A., Peeters, P. C., Dratwa, M., Stolear, J.-C., & Lameire, N. H. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg048 · Cited by 128
Approach to lipoprotein management in 2001 National Cholesterol Guidelines
Grundy, S. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02631-0 · Cited by 128
Self-citation
Who benefits from medical interventions?
Smith, G. D., & Egger, M. (1994) · BMJ · doi:10.1136/bmj.308.6921.72 · Cited by 128
Impact of Metabolic Syndrome on Progression of Aortic Stenosis
Capoulade, R., Clavel, M.-A., Dumesnil, J. G., Chan, K. L., Teo, K. K., Tam, J. W., Côté, N., Mathieu, P., Després, J.-P., & Pibarot, P. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.052 · Cited by 127
Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control
Ray, K. K., Ginsberg, H. N., Davidson, M. H., Pordy, R., Bessac, L., Minini, P., Eckel, R. H., & Cannon, C. P. (2016) · Circulation · doi:10.1161/circulationaha.116.024604 · Cited by 127
Prevalence of Abnormal Glucose Tolerance Following a Transient Ischemic Attack or Ischemic Stroke
Kernan, W. N. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.227 · Cited by 127
Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome
Fortuño, A., San José, G., Moreno, M. U., Beloqui, O., Díez, J., & Zalba, G. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0751 · Cited by 128
Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles
Wang, T.-D., Chen, W.-J., Lin, J.-W., Cheng, C.-C., Chen, M.-F., & Lee, Y.-T. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00296-x · Cited by 125
Childhood trauma and metabolic syndrome in men and women
Lee, C., Tsenkova, V., & Carr, D. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.01.017 · Cited by 125
A Multimethod Quality Improvement Intervention To Improve Preventive Cardiovascular Care: A Cluster Randomized Trial
Ornstein, S., Jenkins, R. G., Nietert, P. J., Feifer, C., Roylance, L. F., Nemeth, L., Corley, S., Dickerson, L., Bradford, W. D., & Litvin, C. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-7-200410050-00008 · Cited by 125
New targets to treat obesity and the metabolic syndrome
Martin, K. A., Mani, M. V., & Mani, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.093 · Cited by 121

Authors: Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., Kris‐Etherton, P. M., McKenney, J. M., Newman, M. A., Schaefer, E. J., Sobel, B. E., Somelofski, C. A., Weinstein, M. C., Brewer, H. B., Cleeman, J. I., Donato, K. A., Ernst, N. D., Hoeg, J. M., Rifkind, B. M., Rossouw, J., Sempos, C. T., Gallivan, J. M., Harris, M. N., & Quint-Adler, L.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1993-06-16
Volume: 269
Issue: 23
Pages: 3015
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.269.23.3015
OpenAlex: W4249825849
Cited by: 27,947
References: 0
FWCI: 282.04
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cited by

Metadata

Record

About these checks

Data sources